CompletedNCT04478981
The Natural History of Patients With Mutations in SEPN1 (SELENON) or LAMA2
Studying Laminin subunit alpha 2-related congenital muscular dystrophy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Radboud University Medical Center
- Principal Investigator
- Nicol VoermansRadboud University Medical Center
- Intervention
- No intervention(other)
- Enrollment
- 38 enrolled
- Eligibility
- 100 years · All sexes
- Timeline
- 2020 – 2023
Study locations (1)
- Radboudumc, Nijmegen, Gelderland, Netherlands
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04478981 on ClinicalTrials.gov